FDA Issues Two Guidances on Payor Communications, Non-Label Information

International Pharmaceutical Regulatory Monitor
A A
The FDA published two final guidances clarifying the information drugmakers can provide to payors and what non-label information they can communicate.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor